Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults

NCT05975840 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

518

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: FLU Q-PAN H5N8 375_B
BIOLOGICAL: FLU Q-PAN H5N8 375_A
BIOLOGICAL: FLU Q-PAN H5N8 750_B
BIOLOGICAL: FLU Q-PAN H5N8 750_A

Sponsor

GlaxoSmithKline